Sign Up Today and Learn More About Coherent Biopharma Stock
Invest in or calculate the value of your shares in Coherent Biopharma or other pre-IPO companies through EquityZen's platform.
Coherent Biopharma Stock (COHB)
Coherent Biopharma is a pahrmaceutical based agency.
About Coherent Biopharma Stock
Founded
2016
Industries
Professional Services, Science and Engineering, Health Care
Coherent Biopharma Press Mentions
Stay in the know about the latest news on Coherent Biopharma
Coherent Biopharma Receives China CDE Clearance to Advance CBP-1008 (Ricorfotide Vedotin, Rico-V) into Phase III Clinical Trial for Epithelial Platinum-Resistant Ovarian Cancer (PROC)
biospace • Jul 22, 2025
Global Peptide Drug Conjugates Market Set for Exponential...
pharmiweb • May 26, 2025
Conjugate drug preparation, preparation method therefor and use thereof
patents • May 04, 2025
Ligand-drug conjugate and use thereof
patents • May 04, 2025
Anti-trpv6 monoclonal antibody and application thereof
patents • May 04, 2025
Coherent Biopharma Management
Leadership team at Coherent Biopharma
Founder and CEO
Robert Huang
Join now and verify your accreditation status to gain access to:
- Coherent Biopharma Current Valuation
- Coherent Biopharma Stock Price
- Coherent Biopharma Management
- Available deals in Coherent Biopharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Coherent Biopharma Cap Table and Funding History by Share Class and Liquidity Preferences
- Coherent Biopharma Revenue and Financials
- Coherent Biopharma Highlights
- Coherent Biopharma Business Model
- Coherent Biopharma Risk Factors
- Coherent Biopharma Research Report from SACRA Research
Trading Coherent Biopharma Stock
How to invest in Coherent Biopharma stock?
Accredited investors can buy pre-IPO stock in companies like Coherent Biopharma through EquityZen funds. These investments are made available by existing Coherent Biopharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Coherent Biopharma stock?
Shareholders can sell their Coherent Biopharma stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
